The abstract is read at the publisher; the summary is JClub's.
Capsule typing of carbapenem-resistant Klebsiella pneumoniae collapses capsular diversity onto 14 dominant KL types that account for 67-77% of burden across WHO regions from 2010–2024.
- Why it matters: Phage therapy is slowed by per-isolate phage matching, but CRKP’s capsular diversity makes routine preparedness difficult. A surveillance-to-treatment shortcut is needed that avoids lineage-specific matching.
- What they did: The study analyzed 26,138 CRKP genomes from 96 countries to identify dominant KL types, then built a repository of 48 strictly lytic phages organized into capsule-defined modules. Clinical testing used KL calls alone to assign modules for 28 isolates spanning two STs per KL type.
- The result: For eight KL types, a single capsule-targeting phage prevented resistant regrowth over 24 h, while six required two-phage modules. Growth was suppressed in every strain, with ST background having no significant effect in 12 of 14 types, enabling lineage-agnostic phage preparedness.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.